Don Dizon and NFN Scout on LGBTQ+ patients with cancer

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Don Dizon, director of the Pelvic Malignancies Program at Lifespan Cancer Institute, head of community outreach and engagement at Legorreta Cancer Center, and director of medical oncology at Rhode Island Hospital, spoke with NFN Scout, executive director of the National LGBT Cancer Network, on Your Stories: Conquering Cancer podcast.

In this episode, published June 25, 2021, Dizon and Scout discuss a need for data on cancer survivors who are members of the LGBTQ+ community—and how oncology can serve as an ally.  

“One of the saddest things we hear is when we hear from a survivor who says that they didn’t bring their partner because they were afraid,” Scout said. “And cancer is such an experience where you need all the support you can get.” 

Listen to this podcast on the Cancer History Project:

Learning What We Don’t Know: Podcast Interview with Dr. Don Dizon and NFN Scout 
By ASCO, Sept. 29, 2021

Why representation matters. Why pronouns matter. And why it matters more than ever for patients with cancer from LGBTQ+ communities to be counted and welcomed.

Scout, MA, PhD, executive director of the National LGBT Cancer Network, tells host Dr. Don Dizon why he believes dismantling the implicit bias LGBTQ+ patients often face begins with doctors and allies asking the uncomfortable questions and feeling comfortable admitting when they “just don’t know what they don’t know.”


This column features the latest posts to the Cancer History Project by our growing list of contributors

The Cancer History Project is a free, web-based, collaborative resource intended to mark the 50th anniversary of the National Cancer Act and designed to continue in perpetuity. The objective is to assemble a robust collection of historical documents and make them freely available.  

Access to the Cancer History Project is open to the public at CancerHistoryProject.com. You can also follow us on Twitter at @CancerHistProj, or follow our podcast.

Is your institution a contributor to the Cancer History Project? Eligible institutions include cancer centers, advocacy groups, professional societies, pharmaceutical companies, and key organizations in oncology. 

To apply to become a contributor, please contact admin@cancerhistoryproject.com.

Table of Contents

YOU MAY BE INTERESTED IN

“When I joined ASCO in 2001, the most important thing to me was networking. I savored the opportunities to come to the annual meeting to meet and to talk with those who had led the studies that would inform standards of care, particularly in gynecologic oncology,” said Don S. Dizon. 
Cancer survivors who identify as lesbian, gay, bisexual, transgender, queer, or anything other than straight and cisgender experience more chronic health conditions, disabilities, and other physical and cognitive limitations than non-LGBTQ+ cancer survivors; however, the prevalence of most conditions was highest among transgender or gender non-conforming individuals, according to a study published in Cancer Epidemiology, Biomarkers & Prevention.

Login